Neko Health's US Expansion Hits Unfamiliar Regulatory Barriers

Neko Health, the AI body-scanning startup, opens its first US clinic in New York after raising $700 million at a $7 billion valuation. Unlike its UK and Sweden operations, the company now faces FDA device oversight, state licensing, and lacks insurance reimbursement for preventive scans—constraints that reshape its business model in ways it has not disclosed.